Quick Picks - Chelsea Therapeutics (CHTP) released preliminary results for its Phase III clinical study, called 306b, which evaluated the efficacy and safety of Northera, the company’s drug … Continue Reading
Read NowLong Ideas - On Tuesday morning, NuPathe Inc. (NASDAQ:PATH) announced the receipt of an $8.5M term loan, just a month after the company firmed up the balance sheet … Continue Reading
Read NowQuick Picks - Medtronic Inc. (NYSE:MDT) posted in-line adjusted earnings and a slight revenue miss in the second quarter of its fiscal year 2013, but expects overall sales growth for … Continue Reading
Read NowQuick Picks - Less than a month after rejecting a previous takeover bid, Taro Pharmaceutical Industries (NYSE:TARO) in August accepted long-time pursuer Sun Pharmaceutical Industries’ $39.50/share purchase price, … Continue Reading
Read NowQuick Picks - After declines in the first half of the week, shares of Threshold Pharmaceuticals (NASDAQ:THLD) rebounded on Thursday morning following an update on the company’s ongoing … Continue Reading
Read NowQuick Picks - With guidance for Natpara’s Biologic License Application (BLA) by mid-2013, and an earnings beat in the third quarter, shares of NPS Pharmaceuticals (NASDAQ:NPSP) climbed 8% … Continue Reading
Read NowQuick Picks - Oncology-focused Celsion Corp. (NASDAQ:CLSN) announced Friday morning that the Phase III HEAT trial met its unblinding milestone, and top-line data will be released in January … Continue Reading
Read Now